# Mana Bio

> AI-native biotech designing lipid nanoparticles for targeted RNA and gene-therapy delivery.

## Why it is interesting

Mana.bio uses ML to optimize LNPs beyond the liver — a16z Bio + Health co-led its $19.5M seed as extrahepatic delivery became the bottleneck for genetic medicine.

## Profile

- **Stage:** other
- **Status:** private
- **Industries:** biotech-life-sciences, healthtech
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Seed (Oct 2023): $19.5M co-led by a16z Bio + Health with Base4, NFX, LionBird (PR Newswire)
- Co-investors: no additional institutional investors disclosed in public sources reviewed 2026-07-24

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz

## Related articles

- https://venturecapitaltracker.com/2026-a16z-hot-portfolio-companies

---
Source: https://venturecapitaltracker.com/startup/mana-bio